ALS

Only one approved treatment for ALS exists, extending life by five months at approximately $1,400 per month. The only approved ALS treatment extends life by just five months and costs approximately $1,400 per month. ALS is more common in men than women, but the sex ratio equalizes to 1:1 at menopause, implicating hormonal changes as a triggering factor. ALS typically strikes between ages 60 and 70 and does not appear in younger populations. ALS is a fatal progressive neurodegenerative disease that affects multiple muscle groups. Immunosuppressant drugs do not work in ALS, suggesting it is probably not a true autoimmune disease. ALS is probably not a true autoimmune disease because immunosuppressant drugs are ineffective against it. ALS is a fatal progressive neurodegenerative disease with an average survival of 3 to 5 years after diagnosis. ALS typically strikes between 60 and 70 years old and does not appear in younger populations. ALS is more common in men than women until menopause, at which point the sex ratio equalizes to approximately 1:1. Heavy metal accumulation has been identified as a contributing factor in some ALS cases. Old spinal column injuries and heavy metal accum…